Coherence for Health

Innovation for New Medicines for Infectious Diseases

image of Coherence for Health

In developing countries, 6 out of 10 people die from infectious diseases. Nearly 1 billion humans suffer from a neglected infectious disease, according to the World Health Organisation. Yet less than 1% of the new drugs placed on the market from 1975 to the turn of the century were developed for these diseases. This book looks at ways of improving the availability of medicines for infectious diseases through strengthened coherence in health, trade, science and technology, development co-operation and finance.



Moving Forward

Solutions and Next Steps

This chapter presents the Noordwijk Medicines Agenda (NMA), which puts forward a set of concrete actions and policy options to promote, in a coherent manner, an open innovation strategy that can deliver new generations of drugs, vaccines and diagnostics for neglected infectious diseases. The chapter highlights what the OECD can bring to this issue and sets out the following areas for action: policy coherence; basic research; new models and policy mechanisms; more open innovation; collaborative mechanisms; global virtual collaborative drug development network; other areas requiring innovation, including regulatory approaches and new technologies and processes; building capacity in disease endemic countries; financing mechanisms; and delivery systems. The message from the NMA is that no one can do this alone; there needs to be more partnerships, networks and policy coherence to achieve the common goals of developing an innovation system that can deal with today’s challenges. This is an opportunity for governments to drive a health innovation strategy that is more efficient and responsive to global public health needs.


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error